Montenegro vs North Macedonia: Prevalence of hypertension, male
Montenegro
49.5%
in 2019
North Macedonia
49.4%
in 2019
Montenegro rank
12th
North Macedonia rank
13th
Prevalence of hypertension, male over time
- Montenegro
- North Macedonia
How they compare
Montenegro currently reports 49.5% against 49.4% in North Macedonia, a difference of 0.1%.
The two have swapped places 3 times across 30 shared years of data; in 1990 it was North Macedonia ahead.
Montenegro ranks 12th and North Macedonia ranks 13th of 192 countries.
Across the 3 decades both report, Montenegro averaged higher in 1 and North Macedonia in 2.
Head to head by decade
| Decade | Montenegro | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 48.0% | 48.2% | 0.1% | North Macedonia |
| 2000s | 48.5% | 48.5% | 0.0% | North Macedonia |
| 2010s | 49.4% | 49.3% | 0.1% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Montenegro or North Macedonia?
- Montenegro, at 49.5% against 49.4% in North Macedonia as of 2019.
- What is the difference in prevalence of hypertension, male between Montenegro and North Macedonia?
- 0.1%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and North Macedonia?
- 30 years are reported by both, from 1990 to 2019.
- How do Montenegro and North Macedonia rank globally for prevalence of hypertension, male?
- Montenegro ranks 12th and North Macedonia ranks 13th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.